Case Study
Proactive Pharmacy Inventory Forecasting for Continuous Availability
Challenge
The client, a hospital pharmacy, was struggling with frequent shortages of critical medicines due to reactive procurement practices. When pharmacists received requests for low-stock items, replenishment delays often impacted patient care. The lack of predictive capability made it difficult to anticipate demand and maintain uninterrupted availability
Industry
Healthcare
Objective
AffinityCore partnered with the client to develop a forecasting mechanism that:
- Utilized 12 months of historical consumption data
- Calculated average weekly usage and weeks of coverage for current stock
- Predicted demand for the next 3 months
- Automated procurement recommendations to ensure timely replenishment
The goal was to shift from reactive to proactive inventory management and improve patient care continuity.
Approach
• Analyzed historical dispensing data for each medicine
• Calculated average weekly consumption and determined weeks of coverage
• Flagged items projected to run out within 4–6 weeks
• Generated automated procurement reports recommending quantities for the next quarter
• Implemented a dashboard for pharmacists to monitor inventory health in real time
Implementation:
Data Collection:
Gathered 12 months of historical dispensing data
Forecasting Model:
Applied consumption trends to predict 3-month demand
Reporting:
Automated reports showing current stock, weeks of coverage, and reorder quantities
Integration:
Linked reports to procurement workflows for faster approvals
Expertise Provided by AffinityCore
Front-End
Back-End
Data Analysis & Forecasting
Inventory Management
Healthcare Compliance
System Integration
Results
Reduction:
Reduced stock-out incidents by 85%
Faster Procurement:
Improved procurement lead time by 40%
Smarter Reorder Automation:
Enhanced pharmacist efficiency through automated reorder recommendations
Inventory Control:
Transitioned from reactive to proactive inventory management, ensuring uninterrupted availability of critical medicines
